Terms: = Leukemia AND SYK, P43405, 6850, ENSG00000165025 AND Prognosis
26 results:
1. FLI1 induces erythroleukemia through opposing effects on UBASH3A and UBASH3B expression.
Wang J; Wang C; Hu A; Yu K; Kuang Y; Gajendran B; Zacksenhaus E; Sample KM; Xiao X; Liu W; Ben-David Y
BMC Cancer; 2024 Mar; 24(1):326. PubMed ID: 38461240
[TBL] [Abstract] [Full Text] [Related]
2. Heterogeneity of Patient-Derived Acute Myeloid leukemia Cells Subjected to syk In Vitro Inhibition.
Brattås MK; Hemsing AL; Rye KP; Hatfield KJ; Reikvam H
Int J Mol Sci; 2022 Nov; 23(23):. PubMed ID: 36499034
[TBL] [Abstract] [Full Text] [Related]
3. GPX1-associated prognostic signature predicts poor survival in patients with acute myeloid leukemia and involves in immunosuppression.
Zhang J; Peng Y; He Y; Xiao Y; Wang Q; Zhao Y; Zhang T; Wu C; Xie Y; Zhou J; Yu W; Lu D; Bai H; Chen T; Guo P; Zhang Q
Biochim Biophys Acta Mol Basis Dis; 2022 Jan; 1868(1):166268. PubMed ID: 34536536
[TBL] [Abstract] [Full Text] [Related]
4. syk inhibition targets acute myeloid leukemia stem cells by blocking their oxidative metabolism.
Polak A; Bialopiotrowicz E; Krzymieniewska B; Wozniak J; Stojak M; Cybulska M; Kaniuga E; Mikula M; Jablonska E; Gorniak P; Noyszewska-Kania M; Szydlowski M; Piechna K; Piwocka K; Bugajski L; Lech-Maranda E; Barankiewicz J; Kolkowska-Lesniak A; Patkowska E; Glodkowska-Mrowka E; Baran N; Juszczynski P
Cell Death Dis; 2020 Nov; 11(11):956. PubMed ID: 33159047
[TBL] [Abstract] [Full Text] [Related]
5. [High Expression Level of SP1, CSF1R, and PAK1 Correlates with Sensitivity of leukemia Cells to the Antibiotic Mithramycin].
Vagapova ER; Lebedev TD; Tikhonova AD; Goikhman BV; Ivanenko KA; Spirin PV; Prassolov VS
Mol Biol (Mosk); 2020; 54(3):522-528. PubMed ID: 32492016
[TBL] [Abstract] [Full Text] [Related]
6. syk Targeting Represents a Potential Therapeutic Option for Relapsed Resistant Pediatric
Serafin V; Porcù E; Cortese G; Mariotto E; Veltri G; Bresolin S; Basso G; Accordi B
Int J Mol Sci; 2019 Dec; 20(24):. PubMed ID: 31817853
[TBL] [Abstract] [Full Text] [Related]
7. The Possible Importance of β3 Integrins for Leukemogenesis and Chemoresistance in Acute Myeloid leukemia.
Johansen S; Brenner AK; Bartaula-Brevik S; Reikvam H; Bruserud Ø
Int J Mol Sci; 2018 Jan; 19(1):. PubMed ID: 29342970
[TBL] [Abstract] [Full Text] [Related]
8. Midostaurin for the treatment of adult patients with newly diagnosed acute myeloid leukemia that is FLT3 mutation-positive.
Garcia JS; Percival ME
Drugs Today (Barc); 2017 Oct; 53(10):531-543. PubMed ID: 29286055
[TBL] [Abstract] [Full Text] [Related]
9. Molecular mechanisms of breast cancer metastasis by gene expression profile analysis.
Zheng T; Wang A; Hu D; Wang Y
Mol Med Rep; 2017 Oct; 16(4):4671-4677. PubMed ID: 28791367
[TBL] [Abstract] [Full Text] [Related]
10. Cooperation between AlphavBeta3 integrin and the fibroblast growth factor receptor enhances proliferation of Hox-overexpressing acute myeloid leukemia cells.
Shah CA; Bei L; Wang H; Altman JK; Platanias LC; Eklund EA
Oncotarget; 2016 Aug; 7(34):54782-54794. PubMed ID: 27340869
[TBL] [Abstract] [Full Text] [Related]
11. Sprouty 2: a novel attenuator of B-cell receptor and MAPK-Erk signaling in CLL.
Shukla A; Rai K; Shukla V; Chaturvedi NK; Bociek RG; Pirruccello SJ; Band H; Lu R; Joshi SS
Blood; 2016 May; 127(19):2310-21. PubMed ID: 26809508
[TBL] [Abstract] [Full Text] [Related]
12. Integration of innate into adaptive immune responses in ZAP-70-positive chronic lymphocytic leukemia.
Wagner M; Oelsner M; Moore A; Götte F; Kuhn PH; Haferlach T; Fiegl M; Bogner C; Baxter EJ; Peschel C; Follows GA; Ringshausen I
Blood; 2016 Jan; 127(4):436-48. PubMed ID: 26508782
[TBL] [Abstract] [Full Text] [Related]
13. Increased syk activity is associated with unfavorable outcome among patients with acute myeloid leukemia.
Boros K; Puissant A; Back M; Alexe G; Bassil CF; Sinha P; Tholouli E; Stegmaier K; Byers RJ; Rodig SJ
Oncotarget; 2015 Sep; 6(28):25575-87. PubMed ID: 26315286
[TBL] [Abstract] [Full Text] [Related]
14. Gefitinib targets ZAP-70-expressing chronic lymphocytic leukemia cells and inhibits B-cell receptor signaling.
Dielschneider RF; Xiao W; Yoon JY; Noh E; Banerji V; Li H; Marshall AJ; Johnston JB; Gibson SB
Cell Death Dis; 2014 Oct; 5(10):e1439. PubMed ID: 25275600
[TBL] [Abstract] [Full Text] [Related]
15. Role of spleen tyrosine kinase in the pathogenesis of chronic lymphocytic leukemia.
Feng G; Wang X
Leuk Lymphoma; 2014 Dec; 55(12):2699-705. PubMed ID: 24547708
[TBL] [Abstract] [Full Text] [Related]
16. Differences in signaling through the B-cell leukemia oncoprotein CRLF2 in response to TSLP and through mutant JAK2.
van Bodegom D; Zhong J; Kopp N; Dutta C; Kim MS; Bird L; Weigert O; Tyner J; Pandey A; Yoda A; Weinstock DM
Blood; 2012 Oct; 120(14):2853-63. PubMed ID: 22915648
[TBL] [Abstract] [Full Text] [Related]
17. Detection of ETV6 gene rearrangements in adult acute lymphoblastic leukemia.
Zhou MH; Gao L; Jing Y; Xu YY; Ding Y; Wang N; Wang W; Li MY; Han XP; Sun JZ; Wang LL; Yu L
Ann Hematol; 2012 Aug; 91(8):1235-43. PubMed ID: 22373549
[TBL] [Abstract] [Full Text] [Related]
18. Dipeptidyl peptidase 2 apoptosis assay determines the B-cell activation stage and predicts prognosis in chronic lymphocytic leukemia.
Danilov AV; Danilova OV; Brown JR; Rabinowitz A; Klein AK; Huber BT
Exp Hematol; 2010 Dec; 38(12):1167-77. PubMed ID: 20817072
[TBL] [Abstract] [Full Text] [Related]
19. Correlation between ZAP-70, phospho-ZAP-70, and phospho-syk expression in leukemic cells from patients with CLL.
Kaplan D; Meyerson HJ; Li X; Drasny C; Liu F; Costaldi M; Barr P; Lazarus HM
Cytometry B Clin Cytom; 2010 Mar; 78(2):115-22. PubMed ID: 20014315
[TBL] [Abstract] [Full Text] [Related]
20. Spleen tyrosine kinase is overexpressed and represents a potential therapeutic target in chronic lymphocytic leukemia.
Buchner M; Fuchs S; Prinz G; Pfeifer D; Bartholomé K; Burger M; Chevalier N; Vallat L; Timmer J; Gribben JG; Jumaa H; Veelken H; Dierks C; Zirlik K
Cancer Res; 2009 Jul; 69(13):5424-32. PubMed ID: 19549911
[TBL] [Abstract] [Full Text] [Related]
[Next]
